Literature DB >> 7945397

Primary rat hepatocytes express cyclin D1 messenger RNA during their growth cycle and during mitogenic transitions induced by transforming growth factor-alpha.

K S Koch1, X P Lu, H L Leffert.   

Abstract

Cyclin D1 messenger RNA expression was investigated in differentiated proliferation-competent primary cultures of adult rat hepatocytes. Periodic expression was observed during the 12-day growth cycle (approximately two population doublings). Upon reaching a quiescent G(o)-state, 4-kb cyclin D1 mRNA levels were undetectable. When G(o) cultures were shifted into defined media without or with 0.2-0.8 nM TGF-alpha, conditions that reinitiate full proliferative transitions synchronously, cyclin D1 mRNA levels were elevated 1.2-4.6-fold, respectively. These findings support the hypothesis that hepatic mitogens stimulate periodic cyclin mRNA expression directly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945397     DOI: 10.1006/bbrc.1994.2430

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes.

Authors:  H Talarmin; C Rescan; S Cariou; D Glaise; G Zanninelli; M Bilodeau; P Loyer; C Guguen-Guillouzo; G Baffet
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations.

Authors:  C Rescan; A Coutant; H Talarmin; N Theret; D Glaise; C Guguen-Guillouzo; G Baffet
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

3.  The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.

Authors:  Jean-Philippe Guégan; Christophe Frémin; Georges Baffet
Journal:  Int J Hepatol       Date:  2012-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.